Leerink Partners Sticks to Their Buy Rating for RegenXBio (RGNX)
Leerink Partners analyst Mani Foroohar maintained a Buy rating on RegenXBio (RGNX – Research Report) on February 20 and set a price target of ...
Penumbra (PEN) Receives a Buy from Leerink Partners
In a report released on February 19, Mike Kratky from Leerink Partners reiterated a Buy rating on Penumbra (PEN – Research Report), with a ...
Myriad Genetics (NASDAQ:MYGN) Lowered to “Hold” Rating by StockNews.com
StockNews.com lowered shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a buy rating to a hold rating in a research ...
Novo’s Weight Loss Drugs Removed from FDA Shortage List
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...
Atyr PHARMA INC (NASDAQ:ATYR) Receives $19.25 Consensus PT from Brokerages
Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Six equities ...
BrightSpring Health Services, Inc. (BTSG): Among the Hot New Stocks to Buy Now
We recently compiled a list of the 10 Hot New Stocks to Buy Now. In this article, we are going to take a look at where ...
UnitedHealth Group’s stock plummets after DOJ investigation report
UnitedHealth Group’s stock plummets after DOJ investigation report - UnitedHealth Group have had a tumultuous past year, ...